Fresenius
Stock
Stock
ISIN: DE0005785604
Ticker: FRE
DE0005785604
FRE
Price
Price
CHART BY
Historical dividends and forecast
Fresenius has so far distributed $1.221 in 2026. The next dividend will be paid on 27.05.2027
$0.458
CHART BY
Frequently asked questions
What is Fresenius's market capitalization?
The market capitalization of Fresenius is $28.10B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Fresenius's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Fresenius is 16.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Fresenius?
Fresenius's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.973. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Fresenius's stock?
Currently, 15 analysts cover Fresenius's stock, with a consensus target price of $62.04. Analyst ratings provide insights into the stock's expected performance.
What is Fresenius's revenue over the trailing twelve months?
Over the trailing twelve months, Fresenius reported a revenue of $26.25B.
What is the EBITDA for Fresenius?
Fresenius's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.77B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Fresenius?
Fresenius has a free cash flow of $1.71B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Fresenius have, and what sector and industry does it belong to?
Fresenius employs approximately 178,394 people. It operates in the Health Care sector, specifically within the Hospital/ Nursing Management industry.
What is the free float of Fresenius's shares?
The free float of Fresenius is 410.55M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $28.10B
- EPS (TTM)
- $2.973
- Free Float
- 410.55M
- P/E ratio (TTM)
- 16.78
- Revenue (TTM)
- $26.25B
- EBITDA (TTM)
- $3.77B
- Free Cashflow (TTM)
- $1.71B
Pricing
- 1D span
- $49.93$50.76
- 52W span
- $40.81$62.35
Analyst Ratings
The price target is $62.04 and the stock is covered by 15 analysts.
Buy
14
Hold
1
Sell
0
Information
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
- Employees
- 178,394
- Industries
- Hospital/ Nursing Management
- Sector
- Health Care
Identifier
- ISIN
- DE0005785604
- Primary Ticker
- FRE
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet